Correlation between culprit vessel/tirofiban and reperfusion bradyarrhythmia in patients with ST-segment elevation myocardial infarction after emergency PCI.

Ma, Z; Ning, B; Wu, D; Liu, W-G; Guo, Y-J

Ma, Z; Ning, B; Wu, D; Liu, W-G; Guo, Y-J.

Affiliation

Ma Z; Department of Cardiology, Fuyang People's Hospital of Anhui Province, Fuyang, China. lvlingma0323@163.com.

Eur Rev Med Pharmacol Sci ; 25(16): 5137-5144, 2021 Aug.

Article in En | MEDLINE | ID: mdl-34486688

Subject(s)

Bradycardia/epidemiology; Percutaneous Coronary Intervention/methods; ST Elevation Myocardial Infarction/therapy; Tirofiban/administration & dosage; Adult; Age Factors; Aged; Aged, 80 and over; Bradycardia/etiology; Coronary Vessels/physiopathology; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors/administration & dosage; Retrospective Studies; Risk Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bradycardia / Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction / Tirofiban Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur Rev Med Pharmacol Sci Year: 2021 Document type: Article

Fulltext

XML

PubMed Links

Search on Google